Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIMI Regulatory News (IMI)

Share Price Information for IMI (IMI)

Share Price is delayed by 15 minutes
Get Live Data
2,816.00    -12.00 (-0.42%)
Bid:
2,814.00
Ask:
2,818.00
Spread: 4.00 (0.142%)
Market Cap: £6.70b
IMI Live PriceLast checked at - London Stock Exchange

Intraday IMI Share Chart

Share repurchase programme

26 Apr 2021 11:23

RNS Number : 6001W
IMI PLC
26 April 2021
 

26 April 2021

IMI plc

LEI: 2138002W9Q21PF751R30

Share repurchase programme

IMI plc (the Company) announces that, in connection with the 12 month share buyback programme of up to £200 million which it announced on 26 April 2021, it is commencing a share buyback programme (the Programme) to purchase shares with a value of up to £100 million subject to remaining within the AGM authority (the 2020 AGM authority is for a maximum of 27,200,000 shares) during the period starting on 26 April 2021 and ending no later than 4 August 2021 (the Engagement Period) in order to reduce the capital of the Company. Shares purchased pursuant to the Programme will be cancelled. The Company has entered into an agreement with J.P. Morgan Securities plc (JPMS plc) under which it has issued an irrevocable instruction to JPMS plc to manage the share buyback programme. JPMS plc will carry out the instruction through the acquisition of ordinary shares in the Company for subsequent repurchase by the Company. This arrangement is in accordance with Chapter 12 of the FCA's Listing Rules and the Company's general authority to repurchase shares. The Programme will also be effected within the parameters of the Market Abuse Regulation 596/2014/EU and the Commission Delegated Regulation 2016/1052/EU (in each case, as in force in the UK from time to time as retained EU law (as defined in the European Union (Withdrawal) Act 2018 as amended from time to time), including where relevant pursuant to the Market Abuse (Amendment)(EU Exit) Regulations 2019). JPMS plc may undertake transactions in shares (which may include sales and hedging activities, in addition to purchases which may take place on any available trading venue or on an over the counter basis) during the Engagement Period in order to manage its market exposure under the Programme. Disclosure of such transactions will not be made by JPMS plc as a result of or as part of the Programme, but JPMS plc will continue to make any disclosures it is otherwise legally required to make.

 

Enquiries to:

 

John O'Shea

IMI

Tel: +44 (0)121 717 3780

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSSEUFSMEFSEFL
Date   Source Headline
1st Apr 20209:56 amRNSTotal Voting Rights
30th Mar 20207:00 amRNSCoronavirus update
26th Mar 20203:58 pmRNSHolding(s) in Company
18th Mar 20204:56 pmRNSDirector/PDMR Shareholding
17th Mar 20204:37 pmRNSDirector/PDMR Shareholding
12th Mar 202010:52 amRNSDirector/PDMR Shareholding
11th Mar 202012:18 pmRNSDirector/PDMR Shareholding
2nd Mar 20203:10 pmRNSTotal Voting Rights
28th Feb 20207:00 amRNSPreliminary results, year ended 31 December 2019
12th Feb 20203:07 pmRNSDirector/PDMR Shareholding
3rd Feb 202010:55 amRNSTotal Voting Rights
15th Jan 202012:15 pmRNSDirector/PDMR Shareholding
13th Jan 20203:31 pmRNSHolding(s) in Company
3rd Jan 202011:54 amRNSBlock listing Interim Review
2nd Jan 20202:04 pmRNSTotal Voting Rights
11th Dec 20192:40 pmRNSDirector/PDMR Shareholding
2nd Dec 201910:20 amRNSTotal Voting Rights
27th Nov 20199:00 amRNSNon-executive director changes
21st Nov 20198:10 amRNSDirector/PDMR Shareholding
14th Nov 201910:04 amRNSDirector/PDMR Shareholding
7th Nov 20197:00 amRNSIMS and Strategy Review conclusions
1st Nov 201910:04 amRNSTotal Voting Rights
9th Oct 20192:07 pmRNSDirector/PDMR Shareholding
1st Oct 201910:17 amRNSTotal Voting Rights
23rd Sep 20197:00 amRNSCompletion of PBM acquisition
16th Sep 20193:51 pmRNSDirector/PDMR Shareholding
11th Sep 20191:08 pmRNSDirector/PDMR Shareholding
2nd Sep 201910:18 amRNSTotal Voting Rights
20th Aug 20197:00 amRNSProposed acquisition of PBM for $85m
14th Aug 20191:42 pmRNSDirector/PDMR Shareholding
12th Aug 20193:40 pmRNSNon-executive director change
1st Aug 20194:17 pmRNSTotal Voting Rights
26th Jul 20197:00 amRNSInterim Results, six months ended 30 June 2019
15th Jul 20194:29 pmRNSDirector Declaration
10th Jul 20192:03 pmRNSDirector/PDMR Shareholding
4th Jul 20194:07 pmRNSBlock listing Interim Review
1st Jul 201910:35 amRNSTotal Voting Rights
12th Jun 201912:38 pmRNSDirector/PDMR Shareholding
10th Jun 20193:18 pmRNSDirector/PDMR Shareholding
3rd Jun 201910:24 amRNSTotal Voting Rights
20th May 20193:18 pmRNSDirector/PDMR Shareholding
15th May 201912:14 pmRNSDirector/PDMR Shareholding
9th May 20192:05 pmRNSResult of AGM
9th May 20197:00 amRNSInterim Management Statement
1st May 201910:44 amRNSTotal Voting Rights
12th Apr 20193:17 pmRNSDirector/PDMR Shareholding
10th Apr 20193:50 pmRNSDirector/PDMR Shareholding
5th Apr 20199:07 amRNSDirector/PDMR Shareholding
1st Apr 201911:36 amRNSTotal Voting Rights
29th Mar 20194:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.